oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prevalence, genotypes and risk factors for vaccine and non-vaccine types of Human Papillomavirus (HPV) infections among Bivalent HPV-16/18 vaccinated and non-vaccinated young women in Ibanda district Uganda: 5 year follow up study
Örebro University, School of Health and Medical Sciences, Örebro University, Sweden. Makerere University College of Health Sciences, Kampala, Uganda.ORCID iD: 0000-0002-7237-7734
Medical Faculty, Lund University, Lund; Global Health, Karolinska Institute, Stockholm.
Örebro University, School of Health and Medical Sciences, Örebro University, Sweden. Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro.
Örebro University, School of Medicine, Örebro University, Sweden. Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro.ORCID iD: 0000-0003-2317-5738
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Keywords [en]
Bivalent HPV16/18 vaccine, Human papillomavirus, genotypes, young women, Uganda
National Category
Medical and Health Sciences Infectious Medicine
Identifiers
URN: urn:nbn:se:oru:diva-44595OAI: oai:DiVA.org:oru-44595DiVA, id: diva2:811346
Available from: 2015-05-11 Created: 2015-05-11 Last updated: 2017-10-17Bibliographically approved
In thesis
1. Human immunodeficiency virus (HIV), human papillomavirus (HPV) and cervical cancer prevention in Uganda: prevalence, risk factors, benefits and challenges of post-exposure profylaxis, screening integration and vaccination
Open this publication in new window or tab >>Human immunodeficiency virus (HIV), human papillomavirus (HPV) and cervical cancer prevention in Uganda: prevalence, risk factors, benefits and challenges of post-exposure profylaxis, screening integration and vaccination
2015 (English)Doctoral thesis, comprehensive summary (Other academic)
Place, publisher, year, edition, pages
Örebro: Örebro university, 2015. p. 154
Series
Örebro Studies in Medicine, ISSN 1652-4063 ; 125
Keywords
HIV, HPV, Cervical cancer, Prevention, Post-exposure prophylaxis, screening integration, vaccination, Uganda
National Category
Obstetrics, Gynecology and Reproductive Medicine
Research subject
Obstetrics and Gynaecology
Identifiers
urn:nbn:se:oru:diva-44517 (URN)978-91-7529-084-3 (ISBN)
Public defence
2015-06-09, Universitetssjukhuset, hörsal C3, Södra Grev Rosengatan, Örebro, 09:00 (English)
Opponent
Supervisors
Available from: 2015-05-04 Created: 2015-05-04 Last updated: 2017-10-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Kumakech, EdwardLillsunde-Larsson, GabriellaHelenius, GiselaKarlsson, MatsAndersson, Sören

Search in DiVA

By author/editor
Kumakech, EdwardLillsunde-Larsson, GabriellaHelenius, GiselaKarlsson, MatsAndersson, Sören
By organisation
School of Health and Medical Sciences, Örebro University, SwedenSchool of Medicine, Örebro University, Sweden
Medical and Health SciencesInfectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 444 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf